Learn More
Medchemexpress LLC RIPK1-IN-4 | 1481641-08-0 | 98.89% | 401.46 | 1 ML

Supplier: Medchemexpress LLC HY1890110MM/1ML
RIPK1-IN-4 (compound 8) is identified as a potent and selective type II kinase inhibitor of receptor interacting protein 1 (RIP1) kinase. It binds to a DLG-out inactive form of RIP1 with IC50s of 16 nM and 10 nM for RIP1 and ADP-Glo kinase, respectively. It is intended for research use only.
- Potent and selective type II kinase inhibitor of RIP1 kinase.
- Binds to a DLG-out inactive form of RIP1.
- High purity: 98.89%.
- Available in solid and solution forms for various research needs.
- Detailed solubility information and protocols for in vitro and in vivo applications are provided.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.